|Download document||Draft guideline on the evaluation of medicinal products for the treatment of irritable bowel syndrome - Revision 1|
|Reference number||CPMP/EWP/785/97 Rev. 1|
|Status||draft: consultation closed|
This guideline intends to address the European Union regulatory position in the main topics of clinical development of new medicinal products in the treatment of patients with irritable bowel syndrome.